Search Results - "Patel, Jeegar"

Refine Results
  1. 1

    Radiological evaluation of OrthAlign-A novel handheld navigation system used in total knee replacement by Patel, Jeegar, Yadav, Krishan, Daga, Rohit, Sadaria, Mohan

    Published in Journal of pharmacy & bioallied science (01-07-2023)
    “…Background: The goal of this research is to determine how well OrthAlign, a novel portable navigation system for total knee replacement, helps surgeons make…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Outcome of single stage anterior and posterior surgery for tuberculous paraplegia by Yadav, Krishan, Mohan, Patel, Daga, Rahul, Sadaria, Mohan

    Published in Journal of pharmacy & bioallied science (01-07-2023)
    “…Background: Morbidity and mortality from tuberculosis, a significant infectious illness, are expected to rise worldwide. The projected number of new cases rose…”
    Get full text
    Journal Article
  5. 5

    Discovery and Optimization of Glucose Uptake Inhibitors by Liu, Kevin G, Kim, Ji-In, Olszewski, Kellen, Barsotti, Anthony M, Morris, Koi, Lamarque, Christophe, Yu, Xuemei, Gaffney, Jack, Feng, Xiao-Jiang, Patel, Jeegar P, Poyurovsky, Masha V

    Published in Journal of medicinal chemistry (28-05-2020)
    “…Aerobic glycolysis, originally identified by Warburg as a hallmark of cancer, has recently been implicated in immune cell activation and growth. Glucose, the…”
    Get full text
    Journal Article
  6. 6

    A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects by Schueller, Olivier, Lohmer, Lauren, Xue, Hongqi, Darpo, Borje, Patel, Jeegar

    Published in Clinical pharmacology in drug development (01-10-2022)
    “…Belumosudil is a selective Rho‐associated, coiled‐coil‐containing protein kinase‐2 inhibitor. In this crossover design thorough QT/QTc study, single…”
    Get full text
    Journal Article
  7. 7

    Phase 1 Studies to Evaluate the Food Effect and Relative Bioavailability of Tablet and Capsule Formulations of Belumosudil in Healthy Adult Subjects by Schueller, Olivier, McDermott, John, Evans, Phil, Lohmer, Lauren, Alabanza, Anginelle, Patel, Jeegar

    Published in Clinical pharmacology in drug development (01-07-2022)
    “…Belumosudil is a selective Rho‐associated coiled‐coil containing protein kinase 2 inhibitor. A capsule formulation was used during early clinical development…”
    Get full text
    Journal Article
  8. 8

    Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]‐Belumosudil in Healthy Men: A Phase 1, Open‐Label, 2‐Part Study by Schueller, Olivier, Skucas, Ed, Regev, Galit, Shaw, Iain, Singh, Nand, Sanghvi, Mitesh, Croft, Marie, Lohmer, Lauren, Alabanza, Anginelle, Patel, Jeegar

    Published in Clinical pharmacology in drug development (01-07-2022)
    “…Belumosudil is a selective Rho‐associated coiled‐coil containing protein kinase 2 (ROCK2) inhibitor. ROCK2 has been shown to drive proinflammatory response and…”
    Get full text
    Journal Article
  9. 9

    652 Anti-PD-L1/IL-15 KD033 activated macrophages and induced anti-tumor immunity in the tumor-microenvironment by Martomo, Stella, Wang, George, Polonskaya, Zhanna, Luna, Xenia, Lu, Dan, Patel, Jeegar

    Published in Journal for immunotherapy of cancer (01-11-2021)
    “…BackgroundKD033 is a clinical-stage bispecific fusion molecule consisting of a high-affinity anti-human-PD-L1 antibody and human IL-15. Previous studies with…”
    Get full text
    Journal Article
  10. 10

    573 A novel human anti-PD1/IL15 bi-functional protein with robust anti-tumor activity and low systemic toxicity by Lu, Dan, Polonskaya, Zhanna, Chang, Tzu-Pei, Martomo, Stella, Luna, Xenia, Zhang, Zhikai, Ng, Stanley, Miyara, Faical, Patel, Jeegar

    Published in Journal for immunotherapy of cancer (01-11-2020)
    “…BackgroundIL-15 is a key cytokine promoting CD8+ T, NK, and NKT cell proliferation and has demonstrated clinical activity in cancer patients without evidence…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO by Patel, Jeegar P, Sengupta, Rajarshi, Bardi, Giuseppe, Khan, Muhammad Z, Mullen-Przeworski, Anna, Meucci, Olimpia

    Published in Journal of neurovirology (01-12-2006)
    “…The chemokine receptor CXCR4 regulates neuronal survival and differentiation and is involved in a number of pathologies, including cancer and human…”
    Get full text
    Journal Article
  13. 13

    Transcriptional profiling of primary human-skin derived mast cell activation by various MRGPRX2 agonists and inhibition with EVO756 by Bagchi, Sreya, Patel, Jeegar, Harden, Jamie

    Published in The Journal of immunology (1950) (01-05-2024)
    “…Abstract Mas-related G-protein coupled receptor X2 (MRGPRX2) is a GPCR expressed predominantly by mast cells and has been implicated to play an important role…”
    Get full text
    Journal Article
  14. 14

    Human immunodeficiency virus gp120-induced apoptosis of human neuroblastoma cells in the absence of CXCR4 internalization by Bardi, Giuseppe, Sengupta, Rajarshi, Khan, Muhammad Z, Patel, Jeegar P, Meucci, Olimpia

    Published in Journal of neurovirology (01-06-2006)
    “…The chemokine receptor CXCR4 functions as human immunodeficiency virus (HIV)-1 coreceptor and is involved in acquired immunodeficiency virus (AIDS)…”
    Get full text
    Journal Article
  15. 15

    Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis by Khan, Muhammad Z, Brandimarti, Renato, Patel, Jeegar P, Huynh, Nha, Wang, Jun, Huang, Ziwei, Fatatis, Alessandro, Meucci, Olimpia

    Published in AIDS research and human retroviruses (01-10-2004)
    “…CXCR4, the specific receptor for the chemokine SDF-1 alpha that also binds CXCR4-using HIV gp120s, affects survival of different cell types, including neurons…”
    Get more information
    Journal Article
  16. 16

    Efficacy of a novel oral, potent, and highly selective PKCt inhibitor in the SCID T-cell transfer colitis model by Harden, Jamie, Whitener, Robert, Kim, Andrea, Hofland, Hans, Patel, Jeegar

    Published in The Journal of immunology (1950) (01-05-2024)
    “…Abstract Protein kinase C family theta isoform (PKCt) is a key kinase downstream of T-cell receptor (TCR) and CD28 co-signaling in T-cells, leading to T-cell…”
    Get full text
    Journal Article
  17. 17

    Selective small-molecule PKC-theta inhibitors effectively block TCR-mediated activation of naïve peripheral blood and tissue resident memory T cells by Whitener, Robert, Harden, Jamie, Hofland, Hans, Patel, Jeegar

    Published in The Journal of immunology (1950) (01-05-2024)
    “…Abstract Immune mediated inflammatory diseases constitute a diverse set of illnesses in which an aberrant immune response damages self-tissue. While progress…”
    Get full text
    Journal Article
  18. 18

    Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo by Martomo, Stella A., Patel, Jeegar

    Published in Cancer Immunology, Immunotherapy (01-06-2023)
    “…KD033 is a clinical-stage immunocytokine composed of a high-affinity anti-human-PD-L1 antibody and the human IL-15/ IL-15 receptor sushi-domain complex. We…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Efficacy of KD033, an anti-human-PD-L1-IL-15 bispecific protein, in human-PD-L1 positive and negative murine tumor models by Martomo, Stella, Lu, Dan, Polonskaya, Zhanna, Luna, Xenia, Zhang, Zhikai, Regev, Galit, Schueller, Olivier, Patel, Jeegar

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e14556 Background: KD033 is a clinical-stage bispecific fusion molecule consisting of a high-affinity anti-human-PD-L1 antibody and human IL-15…”
    Get full text
    Journal Article